Screener
DexCom DXCM Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $249.1M+38.5% | $199.5M+89.3% | $267.3M+76.2% | $283.8M+111% | $179.8M+25.3% | ||
| —— | $67.1M+11.8% | $65.2M+12.8% | $63.6M+15.0% | $63M+20.9% | ||
| —— | $43.3M+26.6% | $35M-19.2% | $45.1M+3.9% | $45.3M+1.3% | ||
| —— | $525.6M+186% | $294M-2.5% | $659.9M+231% | $303M+8.4% | ||
| —— | $76.6M-12.0% | $101.9M-18.2% | $80.5M-27.6% | $94.1M+42.4% | ||
| —— | -$298.5M-398% | $306.6M+201% | $192.8M-8.3% | —— | ||
| —— | -$25M-300% | -$1.52B-95,038% | -$175M+76.2% | -$1.7M-21.4% | ||
| —— | $199.3M-33.3% | —— | $676.6M— | $254.2M+189% |
FAQ
- Where does DexCom's cash flow data come from?
- Every line is extracted from DexCom's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
